| Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia. | |
| | |
MedLine Citation:
|
PMID: 20196714 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Toxic shock syndrome is an uncommon condition in patients with neutropenia. We describe a 44-year-old man who developed toxic shock syndrome caused by hospitalacquired methicillin-resistant Staphylococcus aureus while pancytopenic after chemotherapy. He died of multiorgan failure despite high-level intensive care support and treatment with appropriate antibiotics and intravenous immunoglobulin. This case illustrates the need for a high index of suspicion for toxic shock syndrome in patients with febrile neutropenia, and also highlights the lack of highquality evidence for the various treatment modalities used in this syndrome. |
| | |
Authors:
|
Benoj Varghese; Ritesh Sanghavi; Amjed Aziz; Iain B Gosbell |
Related Documents
:
|
19277834 - Absence of co-morbidity of parkinson disease and restless legs syndrome: a case-control... 15184494 - Fatal case of toxic shock-like syndrome due to group c streptococcus associated with su... 16316304 - Dopamine agonists for the treatment of restless legs syndrome. 20535374 - Imbalance between thyroid hormones and the dopaminergic system might be central to the ... 19277834 - Absence of co-morbidity of parkinson disease and restless legs syndrome: a case-control... 17312144 - Requirement for a complex of wiskott-aldrich syndrome protein (wasp) with wasp interact... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine Volume: 12 ISSN: 1441-2772 ISO Abbreviation: Crit Care Resusc Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-03 Completed Date: 2010-05-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888170 Medline TA: Crit Care Resusc Country: Australia |
Other Details:
|
Languages: eng Pagination: 50-2 Citation Subset: IM |
Affiliation:
|
Department of Intensive Care Medicine, Liverpool Hospital, Sydney, NSW. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Bacterial Agents / therapeutic use* Antineoplastic Combined Chemotherapy Protocols / adverse effects Cross Infection / drug therapy, microbiology* Cytarabine / administration & dosage, adverse effects Etoposide / administration & dosage, adverse effects Fatal Outcome Humans Idarubicin / administration & dosage, adverse effects Leukemia, Myeloid, Acute / complications, drug therapy Male Methicillin-Resistant Staphylococcus aureus* Multiple Organ Failure Pancytopenia / chemically induced, immunology Shock, Septic / drug therapy, microbiology* Staphylococcal Infections / drug therapy, microbiology* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 147-94-4/Cytarabine; 33419-42-0/Etoposide; 58957-92-9/Idarubicin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Triage decisions and outcomes for patients with Triage Priority 3 on the Society of Critical Care Me...
Next Document: Management of acute smoke inhalation injury.